Furthermore, PME ameliorated DSS-induced colitis in mice by improving clinical parameters, including body weight, colon length, and intestinal permeability, and by reducing serum levels of inflammatory cytokines and COX-2/PGE2. The gene discussed is PTGS2; the disease is colitis.